Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kiora Pharmaceuticals Inc...

    NASDAQ: KPRX · Real-Time Price · USD
    3.10
    0.01 (0.32%)
    At close: Jun 06, 2025, 3:05 PM

    Kiora Pharmaceuticals Statistics

    Share Statistics

    Kiora Pharmaceuticals has 3.04M shares outstanding. The number of shares has increased by 1.02% in one year.

    Shares Outstanding

    n/a
    		 3.04M

    Shares Change (YoY)

    n/a
    		 1.02%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.12%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,341

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 25.21K, so 0.83% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 25.21K

    Short % of Shares Out

    n/a
    		 0.83%

    Short % of Float

    n/a
    		 0.86%

    Short Ratio (days to cover)

    n/a
    		 2.02

    Valuation Ratios

    The PE ratio is 3.56 and the forward PE ratio is -1.34. Kiora Pharmaceuticals's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 3.56

    Forward PE

    n/a
    		 -1.34

    PS Ratio

    n/a
    		 0.8

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.5

    P/FCF Ratio

    n/a
    		 1.49

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    Kiora Pharmaceuticals has an Enterprise Value (EV) of 9.04M.

    EV / Sales

    n/a
    		 0.56

    EV / EBITDA

    n/a
    		 1.57

    EV / EBIT

    n/a
    		 1.06

    EV / FCF

    n/a
    		 1.06

    Financial Position

    The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 4.94

    Quick Ratio

    n/a
    		 4.94

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 0.01

    Debt / FCF

    n/a
    		 0.01

    Interest Coverage

    n/a
    		 210.31

    Financial Efficiency

    Return on Equity is 13.95% and Return on Invested Capital is 9.39%.

    Return on Equity

    n/a
    		 13.95%

    Return on Assets

    n/a
    		 9.85%

    Return on Invested Capital

    n/a
    		 9.39%

    Revenue Per Employee

    n/a
    		 $1,335,000

    Profits Per Employee

    n/a
    		 $299,561.08

    Employee Count

    n/a
    		 12

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2.07M

    Effective Tax Rate

    n/a
    		 36.49%

    Stock Price Statistics

    The stock price has increased by -20.57% in the last 52 weeks. The beta is -0.68, so Kiora Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.68

    52-Week Price Change

    n/a
    		 -20.57%

    50-Day Moving Average

    n/a
    		 3.04

    200-Day Moving Average

    n/a
    		 3.39

    Relative Strength Index (RSI)

    n/a
    		 49.01

    Average Volume (20 Days)

    n/a
    		 412,896

    Income Statement

    In the last 12 months, Kiora Pharmaceuticals had revenue of 16.02M and earned 3.59M in profits. Earnings per share was 0.93.

    Revenue

    n/a
    		 16.02M

    Gross Profit

    n/a
    		 16M

    Operating Income

    n/a
    		 4.51M

    Net Income

    n/a
    		 3.59M

    EBITDA

    n/a
    		 5.75M

    EBIT

    n/a
    		 5.68M

    Earnings Per Share (EPS)

    n/a
    		 0.93
    Full Income Statement

    Balance Sheet

    The company has 3.79M in cash and 57.17K in debt, giving a net cash position of 3.74M.

    Cash & Cash Equivalents

    n/a
    		 3.79M

    Total Debt

    n/a
    		 57.17K

    Net Cash

    n/a
    		 3.74M

    Retained Earnings

    n/a
    		 -143.38M

    Total Assets

    n/a
    		 34.02M

    Working Capital

    n/a
    		 21.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 8.56M and capital expenditures -6.26K, giving a free cash flow of 8.55M.

    Operating Cash Flow

    n/a
    		 8.56M

    Capital Expenditures

    n/a
    		 -6.26K

    Free Cash Flow

    n/a
    		 8.55M

    FCF Per Share

    n/a
    		 2.21
    Full Cash Flow Statement

    Margins

    Gross margin is 99.88%, with operating and profit margins of 28.15% and 22.44%.

    Gross Margin

    n/a
    		 99.88%

    Operating Margin

    n/a
    		 28.15%

    Pretax Margin

    n/a
    		 35.33%

    Profit Margin

    n/a
    		 22.44%

    EBITDA Margin

    n/a
    		 35.87%

    EBIT Margin

    n/a
    		 28.15%

    FCF Margin

    n/a
    		 53.39%

    Dividends & Yields

    KPRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 28.13%

    FCF Yield

    n/a
    		 66.93%
    Dividend Details

    Analyst Forecast

    The average price target for KPRX is $10, which is 223.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 223.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 11.79

    Graham Upside

    n/a
    		 281.55%

    Stock Splits

    The last stock split was on Jun 11, 2024. It was a backward split with a ratio of 1:9.

    Last Split Date

    n/a
    		 Jun 11, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:9

    Scores

    Altman Z-Score

    n/a
    		 -5.64

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist